144 related articles for article (PubMed ID: 30541877)
1. Drug and Chemical Glucosidation by Control Supersomes and Membranes from
Chau N; Kaya L; Lewis BC; Mackenzie PI; Miners JO
Drug Metab Dispos; 2019 Mar; 47(3):271-278. PubMed ID: 30541877
[TBL] [Abstract][Full Text] [Related]
2. Arginine-259 of UGT2B7 Confers UDP-Sugar Selectivity.
Nair PC; Chau N; McKinnon RA; Miners JO
Mol Pharmacol; 2020 Dec; 98(6):710-718. PubMed ID: 33008919
[TBL] [Abstract][Full Text] [Related]
3. Morphine glucuronidation and glucosidation represent complementary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7: kinetic, inhibition, and molecular modeling studies.
Chau N; Elliot DJ; Lewis BC; Burns K; Johnston MR; Mackenzie PI; Miners JO
J Pharmacol Exp Ther; 2014 Apr; 349(1):126-37. PubMed ID: 24459244
[TBL] [Abstract][Full Text] [Related]
4. A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids.
Pritchard M; Fournel-Gigleux S; Siest G; Mackenzie P; Magdalou J
Mol Pharmacol; 1994 Jan; 45(1):42-50. PubMed ID: 8302279
[TBL] [Abstract][Full Text] [Related]
5. Acyl glucuronidation and glucosidation of a new and selective endothelin ET(A) receptor antagonist in human liver microsomes.
Tang C; Hochman JH; Ma B; Subramanian R; Vyas KP
Drug Metab Dispos; 2003 Jan; 31(1):37-45. PubMed ID: 12485951
[TBL] [Abstract][Full Text] [Related]
6. Glucosidation of hyodeoxycholic acid by UDP-glucuronosyltransferase 2B7.
Mackenzie P; Little JM; Radominska-Pandya A
Biochem Pharmacol; 2003 Feb; 65(3):417-21. PubMed ID: 12527334
[TBL] [Abstract][Full Text] [Related]
7. Cloning and expression of human UDP-glucuronosyltransferase 1A4 in Bac-to-Bac system.
Qian M; Chen S; Li X; Zeng S
Biochem Biophys Res Commun; 2004 Jun; 319(2):386-92. PubMed ID: 15178418
[TBL] [Abstract][Full Text] [Related]
8. Human UDP-glucuronosyltransferase expression in insect cells: ratio of active to inactive recombinant proteins and the effects of a C-terminal his-tag on glucuronidation kinetics.
Zhang H; Patana AS; Mackenzie PI; Ikushiro S; Goldman A; Finel M
Drug Metab Dispos; 2012 Oct; 40(10):1935-44. PubMed ID: 22782802
[TBL] [Abstract][Full Text] [Related]
9. Glucuronidation of amines and hydroxylated xenobiotics and endobiotics catalyzed by expressed human UGT1.4 protein.
Green MD; Tephly TR
Drug Metab Dispos; 1996 Mar; 24(3):356-63. PubMed ID: 8820428
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation.
Senafi SB; Clarke DJ; Burchell B
Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):233-40. PubMed ID: 7945246
[TBL] [Abstract][Full Text] [Related]
11. Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3.
Green MD; King CD; Mojarrabi B; Mackenzie PI; Tephly TR
Drug Metab Dispos; 1998 Jun; 26(6):507-12. PubMed ID: 9616184
[TBL] [Abstract][Full Text] [Related]
12. Bovine serum albumin decreases Km values of human UDP-glucuronosyltransferases 1A9 and 2B7 and increases Vmax values of UGT1A9.
Manevski N; Moreolo PS; Yli-Kauhaluoma J; Finel M
Drug Metab Dispos; 2011 Nov; 39(11):2117-29. PubMed ID: 21856742
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the zebrafish Ugt repertoire reveals a new class of drug-metabolizing UDP glucuronosyltransferases.
Wang Y; Huang H; Wu Q
Mol Pharmacol; 2014 Jul; 86(1):62-75. PubMed ID: 24728488
[TBL] [Abstract][Full Text] [Related]
14. Uridine diphosphate sugar-selective conjugation of an aldose reductase inhibitor (AS-3201) by UDP-glucuronosyltransferase 2B subfamily in human liver microsomes.
Toide K; Terauchi Y; Fujii T; Yamazaki H; Kamataki T
Biochem Pharmacol; 2004 Apr; 67(7):1269-78. PubMed ID: 15013842
[TBL] [Abstract][Full Text] [Related]
15. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
Kaji H; Kume T
Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
[TBL] [Abstract][Full Text] [Related]
16. SLC35B1 significantly contributes to the uptake of UDPGA into the endoplasmic reticulum for glucuronidation catalyzed by UDP-glucuronosyltransferases.
Ondo K; Arakawa H; Nakano M; Fukami T; Nakajima M
Biochem Pharmacol; 2020 May; 175():113916. PubMed ID: 32179043
[TBL] [Abstract][Full Text] [Related]
17. Identification of human UDP-glucuronosyltransferase responsible for the glucuronidation of niflumic acid in human liver.
Mano Y; Usui T; Kamimura H
Pharm Res; 2006 Jul; 23(7):1502-8. PubMed ID: 16783480
[TBL] [Abstract][Full Text] [Related]
18. Human UDP-glucuronosyltransferase isoforms involved in haloperidol glucuronidation and quantitative estimation of their contribution.
Kato Y; Nakajima M; Oda S; Fukami T; Yokoi T
Drug Metab Dispos; 2012 Feb; 40(2):240-8. PubMed ID: 22028316
[TBL] [Abstract][Full Text] [Related]
19. Homo- and hetero-dimerization of human UDP-glucuronosyltransferase 2B7 (UGT2B7) wild type and its allelic variants affect zidovudine glucuronidation activity.
Yuan L; Qian S; Xiao Y; Sun H; Zeng S
Biochem Pharmacol; 2015 May; 95(1):58-70. PubMed ID: 25770680
[TBL] [Abstract][Full Text] [Related]
20. Glucuronidation of opioids, carboxylic acid-containing drugs, and hydroxylated xenobiotics catalyzed by expressed monkey UDP-glucuronosyltransferase 2B9 protein.
Green MD; Bélanger G; Hum DW; Bélanger A; Tephly TR
Drug Metab Dispos; 1997 Dec; 25(12):1389-94. PubMed ID: 9394029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
